“The large percentage of the public remains unaware of the serious adverse events caused by COVID mRNA injections,” Johnson said during the hearing by the Senate’s Permanent Subcommittee on Investigations, […]
Risk of Therapeutic Misclassification in Long COVID and Post–Acute Infection Syndromes
Conceptual Origins, Diagnostic Uncertainty, and the Structural Basis of Treatment Error John Murphy, M.D., M.P.H., D.P.H. President COVID-19 Long-haul Foundation Abstract Post–acute sequelae of SARS-CoV-2 infection (PASC), commonly termed Long […]
Living With Long COVID: Ten Stories of an Ongoing Illness That Reshaped Lives, Work, and Medicine
Introduction: The Illness That Didn’t End For millions of Americans, COVID-19 ended with a negative test and a return to normal life. But for others, the infection marked the beginning […]
Former Senior NIAID Official Indicted for Concealing Federal Records During COVID-19 Pandemic
Office of Public Affairs A former National Institute of Allergy and Infectious Diseases (NIAID) employee is facing indictment for his role in a scheme to evade Freedom of Information Act […]
NIH RECOVER Clinical Trials and the First Emergence of Interventional Results in Long COVID Research: A Translational Turning Point
A Scholarly Review for Scientific American (Submission-Style Manuscript) John Murphy, M.D., M.P.H., D.P.H., President, COVID-19 Long-Haul Foundation Abstract The NIH RECOVER Initiative represents the largest coordinated research program investigating post–acute […]
Post-Acute SARS-CoV-2 Infection
Historical Context, Paradigm Shift, and Emergence of Immunothrombosis as a Central Framework John Murphy, M.D, M.P.H., D.P.H. President Covid-19 Long-haul Foundation Abstract Post–acute sequelae of SARS-CoV-2 infection (PASC), commonly termed […]
Biodistribution, Pharmacokinetics, and Tissue Uptake of mRNA–Lipid Nanoparticle Vaccines:
A 2026 Comprehensive Review of Mechanisms, Organ Exposure, and Long-Term Safety Implications Joh Murphy, M.D., M.P.H., D.P.H. President COVID-29 Long-haul Foundation Abstract Messenger RNA (mRNA) vaccines delivered via lipid nanoparticles […]
Long COVID Far More Common Than Records Show, and It’s Getting Worse
By StudyFinds Analysis Research led by Hossein Estiri (Massachusetts General Hospital) Estimated 15 Million Americans — Twice As Many As Thought — Still Battling Effects From Coronavirus Years After Diagnosis In […]
Recognition of Long COVID as a Heterogeneous Post-Infectious Syndrome
Toward a Multisystem Endotype Framework for Post–Acute SARS-CoV-2 Disease John Murphy, M.D., M.P.H., D.P.H. President Covid-19 Long-haul Foundation Abstract Long COVID (post–acute sequelae of SARS-CoV-2 infection, PASC) has emerged as […]
Treatment Landscape in Long COVID Has Expanded Beyond “Supportive Care”
A Mechanism-Driven Reframing of Therapeutic Development in Post–Acute SARS-CoV-2 Disease John Murphy, M.D, M.P.H., D.P.H. President COVID Long-haul Foundation Conceptual Shift and Therapeutic Reclassification ABSTRACT For much of the early […]